Call for Original/Review/Meta Articles
Neoadjuvant therapy has been proved as an effective approach for different cancers, including breast cancer, colorectal cancer, and recently pancreatic cancer, etc. Lately, researchers are interested in applying neoadjuvant therapy to HCC and ICC. Yet more evidences need to be accumulated.
Here, HBSN journal (IF: 7.3) is calling for high-quality original articles of clinical research, especially RCT research or comprehensive review/Meta analysis on the topics of neoadjuvant therapy in the treatment of HCC or ICC (iCCA). After being submitted, these articles will be first reviewed by Editor-in-Chief or Vice Editor-in-Chief, and the process will go more effectively.
Submission:
• All submitted articles will go through a peer review process;
• For more information, please read the author instruction: https://hbsn.amegroups.org/pages/view/guidelines-for-authors
• To submit an article online: https://hbsn.amegroups.org/author/submit
• To contact the editor: editor@thehbsn.org.
Yilei Mao
Editor-in-Chief
Hepatobiliary Surgery & Nutrition (HBSN)